98%
921
2 minutes
20
Long non-coding RNAs and microRNAs have evolved as biomarkers and specific therapeutic targets for male infertility. We investigated the seminal plasma and serum expression profiles of TUG1, MALAT1, miR-483, and miR-141 and their targets TGF-β1 and STAT3 in severe male factor infertility. The potential of their serum levels as minimally invasive, clinically accessible, and more feasible biomarkers and their clinical correlations were explored. Thirty non-obstructive azoospermia (NOA) patients, 30 severe oligozoospermia (SO) patients, and 30 healthy fertile men (controls) were enrolled. Compared to controls, seminal plasma and serum TUG1 and miR-141 were downregulated; meanwhile, miR-483 and STAT3 were upregulated in both NOA and SO patients, while MALAT1 was upregulated in NOA but downregulated in SO patients. Seminal plasma TGF-β1 was higher in NOA patients than in controls and SO patients, while its serum levels were not statistically different between the studied groups. NOA patients showcased higher serum STAT3 mRNA expression than SO patients. Seminal plasma and serum levels of most of the tested markers were correlated among NOA and SO patients. Multivariate logistic analysis unraveled the association of serum TUG1 and miR-141 with NOA risk and serum TUG1 and miR-483 with SO risk. A serum-based panel of TUG1/miR-141 and TUG1/miR-483 discriminated NOA (AUC = 0.93) and SO (AUC = 0.972) from controls, respectively. Serum miR-141 was correlated with the hormonal profile in NOA patients. In SO patients, serum TUG1 was correlated with total testosterone levels and abnormal sperm motility, while serum MALAT1 was inversely correlated with the testicular volume. Conclusively, this study introduces a novel serum-based prediction panel of TUG1/miR-141 and TUG1/miR-483 to help enhance the accuracy of NOA and SO diagnosis. Serum MALAT1 and STAT3 could be useful in stratifying NOA and SO. These findings warrant more future investigations for their possible implication in male infertility diagnostics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12116780 | PMC |
http://dx.doi.org/10.1038/s41598-025-03231-0 | DOI Listing |
Neurooncol Adv
August 2025
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, Baltimore, Maryland, USA.
Background: -mutant gliomas can be targeted therapeutically using BRAF-selective inhibitors, yet responses are often transient due to adaptive resistance through reactivation of RAS-ERK signaling. Here, we evaluate the role of SHP2, a central regulator of RAS activity, and SHP2 inhibitors in overcoming resistance to BRAF inhibitors in glioma.
Methods: RNAseq and protein expression in human tissue samples and glioma cell lines were used to identify resistance mechanisms.
J Hum Genet
September 2025
Center for Genetics, National Research Institute for Family Planning, Beijing, China.
Non-obstructive azoospermia (NOA) is often associated with genetic variants. Whole-exome sequencing (WES) has emerged as a powerful tool in studying the genetic diagnosis of NOA and to help identify novel causal gene variants. Minichromosome maintenance domain-containing 2 (MCMDC2), an atypical yet conserved MCM protein, plays a key role in meiotic recombination and the maintenance of fertility.
View Article and Find Full Text PDFFree Radic Biol Med
August 2025
NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan, China; Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genet
Human spermatogenesis is an important physiological process related to programmed cell death. However, which type of programmed cell death playing a key role in normal and abnormal human spermatogenesis remains obscure. This study integrated single-cell, bulk RNA and spatial transcriptome data analysis and found that the ferroptosis signal plays a potential role in spermatogenesis and significantly elevate in testicular samples from humans with non-obstructive azoospermia (NOA) due to various factors.
View Article and Find Full Text PDFHum Reprod Open
August 2025
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Study Question: What is the diagnostic yield and the pre-testicular sperm extraction (TESE) prognostic value of a non-obstructive azoospermia (NOA)-specific virtual gene panel?
Summary Answer: The diagnostic yield in our cohort was 6.1%, and by combining our data with published literature, we identified 11 genes compatible with testicular sperm production and 19 genes associated with no sperm retrieval in carriers of pathogenic (P) or likely pathogenic (LP) mutations.
What Is Known Already: Azoospermia, the most severe form of male infertility, affects ∼1% of the male population, with TESE being the primary treatment option.
Neurooncol Adv
August 2025
Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Background: Patients with IDH-mutant gliomas often experience seizures that significantly affect their quality of life and outcome. Seizure activity may be the result of dysregulation of excitatory (glutamate, Glu) and inhibitory (gamma-aminobutyric acid, GABA) neurotransmitters in peritumoral tissue. A non-invasive measurement of Glu (in combination with glutamine, termed Glx) and GABA is feasible with proton magnetic resonance spectroscopy (H-MRS).
View Article and Find Full Text PDF